To demonstrate the effect of APOE ε4 expression at Aβ-seeding stages on AD-associated pathogenesis, we first examined the aggregation of Aβ42 in AD patient iNs that expressed APOE ε4 from the amyloid-seeding stage. The gene discussed is APOE; the disease is Alzheimer disease.